Skip to content

Pacira BioSciences, Inc. PCRX Other — Purchase obligation

Similar metrics at other companies

Cabot Corporation logo
CBTOther — Recorded Unconditional Purchase Obligation
$29M
Roku, Inc. logo
ROKUOther obligations — Purchase Obligation
$375.26M+123%
NuScale Power logo
SMRPurchase Obligation
$125.21M
Blue Owl Technology Finance Corp. logo
OTFPurchase Obligation
$6.97B
HTF
HTFLPurchase Obligation
$250K
The RealReal logo
REALPurchase Obligation
$17.25M-1.8%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$958.91M-14.5%
Enterprise value$1.23B+2.6%
P/E186.6×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PurchaseObligation.

The official record: Pacira BioSciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s other — purchase obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s other — purchase obligation?
Pacira BioSciences, Inc. (PCRX) reported other — purchase obligation of $8.3M in Q4 2025.
What does other — purchase obligation mean?
Represents the total aggregate amount of legally binding purchase obligations for goods or services within the 'Other' business segment. This metric reflects the company's future contractual commitments to vendors or partners that are not classified under standard operating expenses. Monitoring this figure helps investors assess the company's long-term capital commitment profile and potential future cash outflows.